Action Alert No. 04-40
October 14, 2004

NOTICE OF MEETINGS

OPEN FASB BOARD MEETING
(Board meetings are available by audio webcast and telephone.)

Tuesday, October 19, 2004, 9:00 a.m.

  1. Equity-based compensation.The Board will continue redeliberations of its Exposure Draft, Share-Based Payment, an amendment of FASB Statements No. 123 and 95. The Board plans to address issues related to nonpublic companies. (Estimated 2-hour discussion.)

  2. Open discussion. If necessary, the Board will allow time to discuss minor issues with staff members on technical projects or administrative matters. Those discussions are held following regular Board meetings as topics come up.

OPEN JOINT IASB AND FASB BOARD MEETINGS
(The joint Board meetings will be held in Norwalk and will be available by audio webcast and telephone.)

Tuesday, October 19, 2004, 1:45 p.m.

A representative of the CFA Institute (formerly the Association for Investment Management and Research) will discuss certain of the Institute’s current efforts relating to financial reporting, particularly the development of a comprehensive business reporting model. The joint meeting of the FASB and IASB affords the Boards a unique opportunity to obtain a preview of certain forthcoming proposals for financial reporting by a major international organization of financial statement users that the Boards may wish to consider in the course of several current agenda projects. This meeting will be informational, and no decisions are expected. (Estimated 1-hour discussion.)

Wednesday, October 20, 2004, 9:00 a.m.

  1. Short-term convergence: income taxes. The Boards will consider the practical and cost-benefit considerations of recording deferred tax liabilities on the unremitted earnings of foreign subsidiaries. (Estimated 2-hour discussion.)

  2. Agenda decision: conceptual framework. The Boards will discuss whether to add a joint project to their technical agendas to converge and improve their conceptual frameworks. If they agree to add the project, the Boards will discuss aspects of a proposed plan for the project that addresses matters such as how the project should be conducted, how project priorities should be determined, what the form and structure of the converged framework should be, and what the project’s outputs should be. (Estimated 3-hour discussion.)

  3. Revenue recognition. The Boards will discuss how guidance in the FASB Exposure Draft, Fair Value Measurements, could be applied to example transactions that have been discussed in the revenue recognition project. Specifically, the Boards will consider the following issues: (Estimated 1.5 hour discussion.)

    1. Using prices in actual and proposed exchange transactions to estimate fair values of performance obligations

    2. Using the most advantageous prices (that reflect the effect of volume discounts) to estimate fair values of performance obligations

    3. Estimating fair values of performance obligations consistent with Level 3 of the fair value hierarchy in the absence of immediate access to the reference market

    4. Selecting a point estimate from a range of fair value estimates when no single amount appears to be a better estimate than any other estimate

    5. Using significant entity inputs to estimate fair values of performance obligations.

  4. Financial instruments. The IASB staff will provide the Boards with an oral summary of the recent meeting of the IASB's financial instruments working group. (Estimated 30-minute discussion.)

OPEN FASB EDUCATION SESSION

Thursday, October 21, 2004, 9:00 a.m.

The Board will hold an educational, non-decision-making session to discuss topics that are anticipated to be discussed at its October 27, 2004 Board meeting. Those topics will be posted to the FASB calendar four days prior to the education session.

BOARD ACTIONS

The Board Actions are provided for the information and convenience of constituents who want to follow the Board’s deliberations. All of the conclusions reported are tentative and may be changed at future Board meetings. Decisions are included in an Exposure Draft for formal comment only after a formal written ballot. Decisions in an Exposure Draft may be (and often are) changed in redeliberations based on information provided to the Board in comment letters, at public roundtable discussions, and through other communication channels. Decisions become final only after a formal written ballot to issue a final Statement or Interpretation.

October 6, 2004 Board Meeting

Short-term convergence: phase 1. The Board redeliberated certain provisions of the December 2003 FASB Exposure Draft, Earnings per Share, and made the following decisions:

  1. Mandatorily convertible shares should be used in the calculation of basic earnings per share (EPS). The Board clarified that those shares should be included in the calculation even if the effect is antidilutive.

  2. A contract that may be settled in cash or shares should be subject to the guidance in paragraph 29 of FASB Statement No. 128, Earnings per Share, even if the contract only requires share settlement under certain circumstances. An otherwise cash-settled instrument that contains a provision that requires or permits share settlement under certain circumstances is not a contingently issuable share agreement; therefore, share settlement must be assumed for purposes of computing diluted EPS. The Board decided to make an exception to this guidance for an instrument that only permits share settlement in the case of bankruptcy of the issuer.

Equity-based compensation. The Board continued its redeliberations of the March 2004 FASB Exposure Draft, Share-Based Payment. The Board discussed transition issues for public companies and made the following decisions:

  1. Under an approach labeled modified retrospective application (MRA), the amounts disclosed as the pro forma effects of applying the fair-value-based provisions of FASB Statement No. 123, Accounting for Stock-Based Compensation, would be retrospectively recognized in the financial statements for all prior periods presented. Changes to the amounts as they were originally disclosed in prior periods would be precluded. As of the effective date of the final Statement, both MRA and modified prospective application (MPA) would result in the measurement and attribution of compensation cost for awards for which the requisite service has not been rendered as of that date based on the grant-date fair value calculated and the attribution method applied under Statement 123 (either for recognition or pro forma purposes).

  2. For awards with graded vesting schedules, MRA would result in compensation cost being recognized in the financial statements for all periods presented in a manner consistent with the attribution method applied under Statement 123. As of the effective date of the final Statement, both MRA and MPA would result in the attribution of compensation cost for awards for which the requisite service has not been rendered as of that date using the attribution method applied under Statement 123 (either for recognition or pro forma purposes). The Board decided not to deem as preferable for purposes of making a change in accounting either of the two attribution methods available in the final Statement for awards with graded vesting schedules.

  3. For awards that are accounted for as variable awards under APB Opinion No. 25, Accounting for Stock Issued to Employees, MRA would result in compensation cost being recognized in the financial statements for all periods presented as if that award had been accounted for under Statement 123 from its grant date, with no changes to those amounts as they were originally disclosed in prior periods. As of the effective date of the final Statement, both MRA and MPA result in the recognition of compensation cost for such awards for which the requisite service has not been rendered as of that date over the remaining requisite service period using the grant-date fair value calculated and attribution method applied under Statement 123.

  4. For awards that are classified as liabilities under the original provisions of Statement 123 and measured at intrinsic value, MRA would result in compensation cost being recognized in the financial statements for all periods presented as if that award had been accounted for under Statement 123 from its grant date. For awards outstanding as of the effective date of the final Statement, both MRA and MPA would result in the cumulative effect of a change in accounting principle, net of any related tax effect that would be recognized by initially measuring the liability at fair value as required by the final Statement as of the effective date.

  5. For awards that are classified as equity awards under Statement 123 but would be classified as liabilities under the final Statement, MRA would result in compensation cost being recognized in the financial statements for all periods presented as if that award had been accounted for under Statement 123 from its grant date, with no changes to those amounts as they were originally disclosed under Statement 123 (that is, as equity awards). For awards outstanding as of the effective date of the final Statement, both MRA and MPA would result in the cumulative effect of a change in accounting principle, net of any related tax effect that would be recognized by initially measuring the liability at fair value as required by the final Statement as of the effective date.

  6. With regard to changing the method for estimating forfeitures and estimating compensation cost related to nonrefundable dividend payments, MRA would result in compensation cost being recognized in the financial statements for all periods presented as if that award had been accounted for under Statement 123 from its grant date, with no changes to those amounts as they were originally disclosed under Statement 123 (that is, only actual forfeitures would be recognized in prior periods). As of the effective date of the final Statement, for awards for which the requisite service has not been rendered as of that date, both MRA and MPA would result in an estimate of the number of equity instruments that are not expected to vest and recognition of an amount equal to the compensation cost that would not have been recognized in periods prior to the effective date for those instruments that are not expected to vest as the cumulative effect of a change in accounting principle, net of any related tax effect, upon adoption of the final Statement.

  7. For deferred tax balances, MRA would result in the pro forma effects of applying the fair-value-based provisions of Statement 123 being recognized in the financial statements for all periods presented; therefore, an entity would adjust its deferred tax balance as of the beginning of the earliest period presented as if it had been accounting for deferred taxes under Statement 123. Under either MRA or MPA, no adjustment would be made as of the effective date of the final Statement to any deferred tax balance associated with awards of equity instruments that continue to be classified as equity instruments under the final Statement. However, for purposes of calculating the excess tax benefit, an entity would take into account all compensation cost recognized under Opinion 25, Statement 123, and the final Statement.

    The final Statement would require that the write-off of a deferred tax asset against excess tax benefits recognized in additional paid-in capital not be limited by the type of compensatory arrangement giving rise to the excess tax benefit except compensatory arrangements outside the scope of the final Statement, such as employee stock ownership plans.

    Under both MRA and MPA, an entity would determine the amount of excess tax benefits that would have been accumulated in additional paid-in capital had Statement 123 been adopted prospectively for all awards granted, modified, or settled in fiscal years beginning after December 15, 1994. No adjustment related to that amount would be made to additional paid-in capital at the effective date; however, enterprises would consider that amount in determining the amount of deferred tax asset that may be written off to additional paid-in capital upon settlement of an outstanding award.

  8. The final Statement would not include specific transition guidance relating to compensation cost that may have qualified for capitalization. If an enterprise determines that the pro forma amounts calculated pursuant to Statement 123 and reported in prior periods are inaccurate because of mathematical mistakes, mistakes in the application of accounting principles, or oversight or misuse of facts that existed at the time the financial statements were prepared, it shall follow the guidance in Opinion 20 related to such events.

  9. The transition guidance in paragraph 24 of the Exposure Draft that requires pro forma disclosures only for those prior periods presented in which awards under share-based payment arrangements with employees are accounted for under the intrinsic value method of Opinion 25 should be retained.

  10. Under MRA, companies should present the statement of cash flows in accordance with the final Statement for all periods presented. Under MPA, companies should present the statement of cash flows in accordance with the final Statement on a prospective basis after adoption of the final Statement.

  11. Under the final Statement, modification of a deep out-of-the-money award with a service condition to accelerate its vesting would not be accounted for as a modification if the modification does not result in a change in the substantive terms of the award.

  12. Under both MRA and MPA, for awards outstanding as of the effective date that are measured at intrinsic value because it is not reasonably possible to measure their fair value in accordance with Statement 123, an entity would measure those awards at intrinsic value through settlement.

Financial instruments: liabilities and equity. The Board discussed and agreed that an issuer would use the following approach for distinguishing whether a single component instrument would be classified as a liability or equity (words in italics are defined as described below):

  1. An instrument that does not embody a settlement obligation is equity (unless it is an asset). An example is a share (common or preferred) that is not subject to redemption requirements.

  2. An instrument that establishes a direct ownership relationship between the issuer and the holder is equity, even if it embodies a settlement obligation. An example is a common share that is mandatorily redeemable at fair value.

  3. An instrument that establishes an indirect ownership relationship that would be settled or ultimately settled by issuing an instrument that establishes a direct ownership relationship is equity (such as a physically settled written call option). Otherwise, the instrument is a liability (such as a net cash-settled written call option).

  4. An instrument that embodies a settlement obligation and does not establish either a direct or indirect ownership relationship is a liability. An example is a written put option.

The Board also agreed on the following definitions in applying the approach:

  1. A settlement obligation is a present obligation of an entity settled prior to liquidation to:

    1. Transfer or provide use of assets
    2. Use assets to provide services
    3. Stand ready to use assets to provide services or transfer or provide use of assets
    4. Issue shares or other instruments (fixed or variable number).

  2. A direct ownership relationship is established by an instrument of an entity or consolidated subsidiary (reference instrument) that:

    1. Is (or together with other instruments is) the most subordinated interest(s) issued by the entity or consolidated subsidiary
    2. Shares pro rata in the earnings and losses of the entity with other instruments meeting characteristic 2(a).

  3. An indirect ownership relationship is established by an instrument of an entity in which the counterparty’s payoff at settlement is based on and varies in the same direction as the fair value of the reference instrument and does not contain a contingency provision that is based on an external market or index.

FUTURE OPEN MEETINGS

The following is a list of open meetings tentatively scheduled through November. All meetings are held in Norwalk, Connecticut, unless otherwise noted. Because schedules may change, please check the FASB calendar before finalizing your plans. Revisions to this list since the last issue of Action Alert are highlighted in bold.

Wednesday, October 27, 2004—FASB Board Meeting
Wednesday, October 27, 2004—FASB Education Session
Tuesday, November 2, 2004—Liaison Meeting with the Institute of Management Accountants
Wednesday, November 3, 2004—FASB Board Meeting
Wednesday, November 3, 2004—FASB Education Session
Wednesday, November 10, 2004—FASB Board Meeting
Wednesday, November 10, 2004—FASB Education Session
Tuesday, November 16, 2004—FASB Education Session
Wednesday, November 17, 2004—FASB Board Meeting
Wednesday, November 17, 2004—Emerging Issues Task Force Meeting
Thursday, November 18, 2004—Emerging Issues Task Force Meeting
Wednesday, November 24, 2004—FASB Board Meeting
Wednesday, November 24, 2004—FASB Education Session
Tuesday, November 30, 2004—FASB Board Meeting
Tuesday, November 30, 2004—FASB Education Session